The 2007 WHO Classification of Tumours of the Central Nervous System
By D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger, A. Jouvet, B. Scheithauer, P. Kleihues. Acta Neuropathologica, 2007
12,930 citations recorded by the source corpus.
The fourth edition of the World Health Organization (WHO) classification of tumours of the central nervous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of the pineal region, pituicytoma and spindle cell oncocytoma of the adenohypophysis. Histological variants were added if there was evidence of a different age distribution, location, genetic profile or clinical behaviour; these included pilomyxoid astrocytoma, anaplastic medulloblastoma and medulloblastoma with extensive nodularity. The WHO grading scheme and the sections on genetic profiles were updated and the rhabdoid tumour predisposition syndrome was added to the list of familial tumour syndromes typically involving the nervous system. As in the previous, 2000 edition of the WHO ‘Blue Book’, the classification is accompanied by a concise commentary on clinico-pathological characteristics of each tumour type. The 2007 WHO classification is based on the consensus of an international Working Group of 25 pathologists and geneticists, as well as contributions from more than 70 international experts overall, and is presented as the standard for the definition of brain tumours to the clinical oncology and cancer research communities world-wide.
Subfields: Genetics, Neurology
View Paper: https://www.semanticscholar.org/paper/85648eadb648f2f15adf2fe7cacf60101ec861cb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Guido Reifenberger
- Michael Weller
- K. Helin
- R. Jenkins
- Liqun Luo
- Jeremy N. Rich
- William C. Hahn
- Richard J. Gilbertson
In Neurology
- Vishwesh Nath
- Dong Yang
- Holger R. Roth
- Michelle Monje
- Marco Prinz
- Ali Hatamizadeh
- Daguang Xu
- Yucheng Tang
Citations in the corpus
- Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells (2013, background): “Glioblastoma multiforme (GBM) is the most common and most lethal primary brain cancer (Louis et al., 2007).”
- Mosaic Analysis with Double Markers (MADM) Reveals Tumor Cell-of-Origin in Glioma (2011, positive): “This observation is consistent with previous findings in both mouse models and human patients (Alcantara Llaguno et al., 2009; Louis et al., 2007; Wang et al., 2009; Zhu et al., 2005) and has been considered as evidence to support the NSC origin of gliomas.”
- Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. (2011, background): “Glioblastoma (GBM) is the most common malignant brain tumor of adults (Louis et al., 2007), with poor prognosis regardless of treatment (Nicholas, 2007).”
- Swin UNETR: Swin Transformers for Semantic Segmentation of Brain Tumors in MRI Images (2022, background): “There are over 120 types of brain tumors that affect the human brain [28].”